Ratio of remnant-like particle-cholesterol to serum total triglycerides isan effective alternative to ultracentrifugal and electrophoretic methods in the diagnosis of familial type III hyperlipoproteinemia
T. Wang et al., Ratio of remnant-like particle-cholesterol to serum total triglycerides isan effective alternative to ultracentrifugal and electrophoretic methods in the diagnosis of familial type III hyperlipoproteinemia, CLIN CHEM, 45(11), 1999, pp. 1981-1987
Background: Familial type III hyperlipoproteinemia (HLP) is characterized b
y the presence of beta-migrating VLDL (beta-VLDL) and increased risk of car
diovascular disease. Assessment of plasma beta-VLDL is achieved by measurin
g the ratio of VLDL-cholesterol (VLDL-C) to total plasma triglycerides (TGs
) or by detecting beta-VLDL in total VLDL. The objective of this study was
to compare the clinical utility of the ratio of remnant-like particle-chole
sterol (RLP-C) to total TGs with that of the current methods for diagnosing
type III HLP.
Methods: Detection of beta-VLDL by electrophoresis of VLDL was used to defi
ne type III HLP. Twenty-eight patients with type III HLP and 43 subjects la
cking beta-VLDL were investigated. Fasting TG concentrations were >2.26 mmo
l/L in all subjects. Subjects were separated into three groups: group 1, se
rum total cholesterol less than or equal to 5.18 mmol/L (n = 11); group 2,
total cholesterol >5.18 mmol/L and TGs between 2.26 and 9.04 mmol/L (n = 51
); and group 3, TGs >9.04 mmol/L (n = 9).
Results: In group 2, a RLP-C-to-total TG molar ratio greater than or equal
to 0.23 (greater than or equal to 0.10 when using mg/dL) and a VLDL-C-to-to
tal TG molar ratio greater than or equal to 0.69 (greater than or equal to
0.30 when using mg/dL) correctly classified 94% and 90% of the subjects, re
spectively. The utility of the RLP-C-to-total TG ratio in diagnosing type I
II HLP decreased in patients in the other two groups.
Conclusion: When used in an appropriate target population, the RLP-C-to-tot
al TG ratio is a convenient and effective alternative to ultracentrifugal a
nd electrophoretic methods for diagnosing-type III HLP. (C) 1999 American A
ssociation for Clinical Chemistry.